Small decreases in HbA1c, BP could lower CVD risk in type 2 diabetes

10/6/2011 | InternalMedicineNews.com (free registration)

A Dutch study presented at the annual meeting of the European Society for the Study of Diabetes estimated that a 0.5% decrease in hemoglobin A1c levels and a 10 Hg/mm decrease in systolic blood pressure could help reduce the risks of heart attack, stroke and other cardiovascular complications in type 2 diabetes patients by 10% over five years.

View Full Article in:

InternalMedicineNews.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC